1)Shoskes DA, Nickel JC, Dolinga R, et al:Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology 73:538-542, 2009
2)Magri V, Wagenlehner F, Perletti G, et al:Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts:sexual function domain improves correlations. J Urol 184:2339-2345, 2010
3)Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al:The National Institutes of Health chronic prostatitis symptom index:development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162:369-375, 1999
4)Nickel JC, Downey J, Clark J, et al:Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men:a randomized placebo-controlled multicenter trial. Urology 62:614-617, 2003
5)Nickel JC and Sorensen R:Transurethral microwave thermotherapy for nonbacterial prostatitis:a randomized double-blind sham controlled study using new prostatitis specific assessment questionnaires. J Urol 155:1950-1954, 1996
6)Alexander RB, Propert KJ, Schaeffer AJ, et al:Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome:a randomized, double-blind trial. Ann Intern Med 141:581-589, 2004
7)Jeong CW, Lim DJ, Son H, et al:Treatment for chronic prostatitis/chronic pelvic pain syndrome:levofloxacin, doxazosin and their combination. Urol Int 80:157-161, 2008
8)Mehik A, Alas P, Nickel JC, et al:Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome:a prospective, randomized, double-blind, placebo-controlled, pilot study. Urology 62:425-429, 2003
9)Kunishima Y, Takeyama K, Takahashi S, et al:Gatifloxacin treatment for chronic prostatitis:a prospective multicenter clinical trial. J Infect Chemother 14:137-140, 2008
10)Takeyama K, Mitsuzawa H, Nishitani C, et al:The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3. Antimicrob Agents Chemother 51:162-168, 2007
. J Antimicrob Chemother 46:91-94, 2000
12)Hara S, Ishimatsu Y, Mukae H, et al:Anti-inflammatory effects of garenoxacin on IL-8 production and ERK1/2 activation induced by lipopolysaccharides in A549 and THP-1 cells. Eur J Pharmacol 668:264-270, 2011
13)Tsivkovskii R, Sabet M, Tarazi Z, et al:Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells:implications for aerosol MP-376(levofloxacin solution for inhalation)treatment of chronic pulmonary infections. FEMS Immunol Med Microbiol 61:141-146, 2011